Donaldson Reports Second Quarter Fiscal Year 2026 Sales and Earnings
Record second quarter sales of
GAAP EPS of
Announced margin-accretive Facet acquisition, strengthening core filtration product portfolio
Fiscal 2026 sales, adjusted operating margin and adjusted EPS forecasted at all-time highs
“This quarter, the Donaldson team delivered record sales, strengthened the foundation to meet strong customer demand in key, high-margin businesses and made further progress on our footprint optimization initiatives, despite near-term challenges,” said
“Supported by our strong backlogs and expected improvement in operating performance in the second half of the year, we project record sales, operating margin and earnings in fiscal 2026. The Donaldson team is committed to solving our customers’ challenges through our technology-led solutions, strategically investing for our future, and generating long-term shareholder value.”
|
_________________________________ 1 All EPS figures refer to diluted EPS. |
|
2 Second quarter fiscal 2026 results include pre-tax charges of |
|
3 Adjusted figures are non-GAAP financial measures that excludes the impact of certain items not related to ongoing operations. The tables attached to this press release include a reconciliation of GAAP to non-GAAP measures. |
Second Quarter Operating Results
Sales of
|
|
Three Months Ended |
|
Six Months Ended |
||||||||
|
|
|
|
|
||||||||
|
|
Reported % Change |
|
Constant Currency % Change |
|
Reported % Change |
|
Constant Currency % Change |
||||
|
Mobile Solutions segment |
|
|
|
|
|
|
|
||||
|
Off-Road |
7.8 |
% |
|
4.1 |
% |
|
6.9 |
% |
|
4.4 |
% |
|
On-Road |
(9.2 |
) |
|
(11.3 |
) |
|
(19.2 |
) |
|
(20.5 |
) |
|
Aftermarket |
1.1 |
|
|
(1.9 |
) |
|
3.8 |
|
|
1.8 |
|
|
Total Mobile Solutions segment |
1.6 |
|
|
(1.4 |
) |
|
3.1 |
|
|
1.0 |
|
|
|
|
|
|
|
|
|
|
||||
|
Industrial Solutions segment |
|
|
|
|
|
|
|
||||
|
Industrial Filtration Solutions |
7.2 |
|
|
4.6 |
|
|
4.4 |
|
|
2.5 |
|
|
Aerospace and Defense |
(19.4 |
) |
|
(19.5 |
) |
|
(13.3 |
) |
|
(14.0 |
) |
|
Total Industrial Solutions segment |
2.4 |
|
|
0.2 |
|
|
1.2 |
|
|
(0.4 |
) |
|
|
|
|
|
|
|
|
|
||||
|
Life Sciences segment |
|
|
|
|
|
|
|
||||
|
Total Life Sciences segment |
16.2 |
|
|
9.8 |
|
|
14.6 |
|
|
9.8 |
|
|
|
|
|
|
|
|
|
|
||||
|
|
3.0 |
% |
|
(0.1 |
)% |
|
3.5 |
% |
|
1.3 |
% |
|
|
|
|
|
|
|
|
|
||||
Mobile Solutions segment (Mobile) sales increased 1.6% as pricing and currency translation more than offset volume declines. Off-Road sales increased 7.8% as a result of improving end-market conditions. On-Road sales decreased 9.2% due to lower global truck production. Aftermarket sales rose 1.1% from solid independent channel sales, partially offset by declines in the OE channel after comparing against strong order volume in the prior year.
Industrial Solutions segment (Industrial) sales rose 2.4% versus prior year as currency translation and pricing were partially offset by volume declines, particularly in Aerospace and Defense. Industrial Filtration Solutions (IFS) sales increased 7.2%, driven by robust growth in
Life Sciences segment (Life Sciences) sales increased 16.2% as a result of strong new equipment sales in Food and Beverage and Disk Drive, combined with benefits from currency translation.
Gross margin was 33.5%, down versus 35.2% in 2025. Operating inefficiencies, including those related to production shifts to support higher demand in
Operating expenses as a percentage of sales were 20.2%, favorable by 50 basis points versus 20.7% in 2025, driven by cost optimization initiatives and expense discipline, partially offset by restructuring and other charges. Adjusted operating expenses as a percentage of sales were 19.7% compared with 20.0% a year ago.
Operating income as a percentage of sales (operating margin) was 13.2% versus 14.4% in 2025 as a result of the gross margin decline. Adjusted operating margin was 14.0%.
Interest expense was
Year to date, Donaldson paid
During the quarter, the Company entered into a definitive agreement to acquire Facet, a provider of fuel and fluid filtration solutions for mission-critical applications, in an all-cash transaction valued at approximately
Updated Fiscal 2026 Outlook
Adjusted full-year EPS is expected to be within a range of
Mobile sales are expected to grow 2% to 6% year over year compared with flat to 4% growth previously, due to favorable currency translation. Off-Road sales are projected to grow mid-single digits as select end-market conditions improve following weakness in the prior year. On-Road sales are forecast to be flat as a result of muted global truck production. Aftermarket sales are expected to increase mid-single digits from continued market share gains and vehicle utilization rates.
Industrial sales are projected to be in a range of between -1% and 3% compared with 2025, below previous guidance of between 2% and 6% as a result of lower volumes. IFS sales are forecast to grow low-single digits with increases across several key businesses, including dust collection and
Life Sciences sales are expected to increase between 5% and 9% year over year, above previous guidance of 1% and 5% due to favorable currency translation combined with increased volume. Food and Beverage and Disk Drive sales are forecast to drive the growth versus 2025.
Adjusted 2026 operating margin is expected to be between 16.0% and 16.4%, down from previous guidance of between 16.2% and 16.8%, driven by gross margin. Fiscal 2025 operating margin was 13.4%, or 15.7% on an adjusted basis. The year-over-year improvement in operating margin is driven by gross margin expansion and operating expense leverage.
Interest expense is estimated to be approximately
Capital expenditures are forecast to be between
Miscellaneous
The Company will webcast its second quarter fiscal 2026 earnings conference call today at
Statements in this release regarding future events and expectations, such as forecasts, plans, trends and projections relating to the Company’s business and financial performance, are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 and are identified by words or phrases such as “will likely result,” “are expected to,” “will continue,” “will allow,” “estimate,” “project,” “believe,” “expect,” “anticipate,” “forecast,” “plan” and similar expressions. These forward-looking statements speak only as of the date such statements are made and are subject to risks and uncertainties that could affect the Company’s performance and could cause the Company’s actual results for future periods to differ materially from any opinions or statements expressed. These factors include, but are not limited to, challenges in global operations; impacts of global economic, industrial and political conditions on product demand; impacts from unexpected events; effects of unavailable raw materials, significant demand fluctuations or material cost changes; inability to attract and retain qualified personnel; inability to meet customer demand; inability to maintain competitive advantages; threats from disruptive technologies; effects of highly competitive markets with pricing pressure; exposure to customer concentration in certain cyclical industries; inability to manage productivity improvements; inability to achieve commitments related to sustainability, results of execution of any acquisition, divestiture and other strategic transactions; vulnerabilities associated with information technology systems and security; inability to protect and enforce intellectual property rights; costs associated with governmental laws and regulations; impacts of foreign currency fluctuations; and effects of changes in capital and credit markets. These and other factors are described in Part I, Item 1A, “Risk Factors” of the Company’s Annual Report on Form 10-K for the fiscal year ended
About
Founded in 1915, Donaldson (NYSE: DCI) is a global leader in technology-led filtration products and solutions, serving a broad range of industries and advanced markets. Diverse, skilled employees at over 150 locations on six continents partner with customers – from small business owners to R&D organizations and the world’s biggest OEM brands. Donaldson solves complex filtration challenges through three primary segments: Mobile Solutions, Industrial Solutions and Life Sciences. Additional information is available at www.Donaldson.com.
|
CONDENSED CONSOLIDATED STATEMENTS OF EARNINGS (In millions, except per share amounts) (Unaudited) |
|||||||||||||||||||||
|
|
Three Months Ended |
|
Six Months Ended |
||||||||||||||||||
|
|
|
|
|
||||||||||||||||||
|
|
|
2026 |
|
|
|
2025 |
|
|
Change |
|
|
2026 |
|
|
|
2025 |
|
|
Change |
||
|
Net sales |
$ |
896.3 |
|
|
$ |
870.0 |
|
|
3.0 |
% |
|
$ |
1,831.7 |
|
|
$ |
1,770.1 |
|
|
3.5 |
% |
|
Cost of sales |
|
596.5 |
|
|
|
564.1 |
|
|
5.7 |
|
|
|
1,203.1 |
|
|
|
1,144.6 |
|
|
5.1 |
|
|
Gross profit |
|
299.8 |
|
|
|
305.9 |
|
|
(2.0 |
) |
|
|
628.6 |
|
|
|
625.5 |
|
|
0.5 |
|
|
Selling, general and administrative |
|
162.5 |
|
|
|
159.2 |
|
|
2.1 |
|
|
|
332.1 |
|
|
|
325.3 |
|
|
2.1 |
|
|
Gain on sale of fixed assets |
|
— |
|
|
|
— |
|
|
— |
|
|
|
(9.3 |
) |
|
|
— |
|
|
100.0 |
|
|
Research and development |
|
18.6 |
|
|
|
21.2 |
|
|
(11.7 |
) |
|
|
37.8 |
|
|
|
43.9 |
|
|
(13.7 |
) |
|
Operating expenses |
|
181.1 |
|
|
|
180.4 |
|
|
0.5 |
|
|
|
360.6 |
|
|
|
369.2 |
|
|
(2.3 |
) |
|
Operating income |
|
118.7 |
|
|
|
125.5 |
|
|
(5.6 |
) |
|
|
268.0 |
|
|
|
256.3 |
|
|
4.5 |
|
|
Interest expense |
|
7.7 |
|
|
|
5.9 |
|
|
29.0 |
|
|
|
14.8 |
|
|
|
11.4 |
|
|
30.4 |
|
|
Other income, net |
|
(5.6 |
) |
|
|
(5.4 |
) |
|
5.2 |
|
|
|
(10.9 |
) |
|
|
(10.6 |
) |
|
3.9 |
|
|
Earnings before income taxes |
|
116.6 |
|
|
|
125.0 |
|
|
(6.7 |
) |
|
|
264.1 |
|
|
|
255.5 |
|
|
3.3 |
|
|
Income taxes |
|
24.1 |
|
|
|
29.1 |
|
|
(17.1 |
) |
|
|
57.7 |
|
|
|
60.6 |
|
|
(4.8 |
) |
|
Net earnings |
$ |
92.5 |
|
|
$ |
95.9 |
|
|
(3.6 |
)% |
|
$ |
206.4 |
|
|
$ |
194.9 |
|
|
5.9 |
% |
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||
|
Weighted average shares – basic |
|
115.6 |
|
|
|
119.6 |
|
|
(3.3 |
)% |
|
|
115.8 |
|
|
|
119.8 |
|
|
(3.3 |
)% |
|
Weighted average shares – diluted |
|
117.9 |
|
|
|
121.4 |
|
|
(2.9 |
)% |
|
|
117.8 |
|
|
|
121.7 |
|
|
(3.1 |
)% |
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||
|
Net EPS – basic |
$ |
0.80 |
|
|
$ |
0.80 |
|
|
(0.3 |
)% |
|
$ |
1.78 |
|
|
$ |
1.63 |
|
|
9.5 |
% |
|
Net EPS – diluted |
$ |
0.78 |
|
|
$ |
0.79 |
|
|
(0.7 |
)% |
|
$ |
1.75 |
|
|
$ |
1.60 |
|
|
9.3 |
% |
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||
|
Dividends paid per share |
$ |
0.30 |
|
|
$ |
0.27 |
|
|
11.1 |
% |
|
$ |
0.60 |
|
|
$ |
0.54 |
|
|
11.1 |
% |
|
Note: Amounts may not foot due to rounding. |
|||||||||||||||||||||
|
CONDENSED CONSOLIDATED BALANCE SHEETS (In millions) (Unaudited) |
|||||
|
|
|
|
|
||
|
|
|
2026 |
|
|
2025 |
|
Assets |
|
|
|
||
|
Current assets: |
|
|
|
||
|
Cash and cash equivalents |
$ |
194.4 |
|
$ |
180.4 |
|
Accounts receivable, net |
|
647.9 |
|
|
662.2 |
|
Inventories, net |
|
555.8 |
|
|
513.6 |
|
Prepaid expenses and other current assets |
|
128.9 |
|
|
105.5 |
|
Total current assets |
|
1,527.0 |
|
|
1,461.7 |
|
Property, plant and equipment, net |
|
645.3 |
|
|
644.5 |
|
|
|
504.1 |
|
|
493.6 |
|
Intangible assets, net |
|
95.0 |
|
|
97.4 |
|
Other long-term assets |
|
289.0 |
|
|
280.0 |
|
Total assets |
$ |
3,060.4 |
|
$ |
2,977.2 |
|
|
|
|
|
||
|
Liabilities and Stockholders’ Equity |
|
|
|
||
|
Current liabilities: |
|
|
|
||
|
Short-term borrowings |
$ |
— |
|
$ |
31.2 |
|
Current maturities of long-term debt |
|
6.5 |
|
|
6.7 |
|
Accounts payable |
|
348.8 |
|
|
368.6 |
|
Accrued employee compensation and related taxes |
|
122.9 |
|
|
144.3 |
|
Income taxes payable |
|
13.3 |
|
|
43.9 |
|
Other current liabilities |
|
174.4 |
|
|
162.5 |
|
Total current liabilities |
|
665.9 |
|
|
757.2 |
|
Long-term debt |
|
674.3 |
|
|
630.4 |
|
Non-current income taxes payable |
|
19.7 |
|
|
19.0 |
|
Deferred income taxes |
|
10.9 |
|
|
10.5 |
|
Other long-term liabilities |
|
114.5 |
|
|
106.6 |
|
Total liabilities |
|
1,485.3 |
|
|
1,523.7 |
|
|
|
|
|
||
|
Total stockholders’ equity |
|
1,575.1 |
|
|
1,453.5 |
|
Total liabilities and stockholders’ equity |
$ |
3,060.4 |
|
$ |
2,977.2 |
|
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (In millions) (Unaudited) |
|||||||
|
|
Six Months Ended |
||||||
|
|
|
||||||
|
|
|
2026 |
|
|
|
2025 |
|
|
Operating Activities |
|
|
|
||||
|
Net earnings |
$ |
206.4 |
|
|
$ |
194.9 |
|
|
Adjustments to reconcile net earnings to net cash provided by operating activities: |
|
|
|
||||
|
Depreciation and amortization |
|
48.9 |
|
|
|
50.5 |
|
|
Deferred income taxes |
|
0.8 |
|
|
|
(13.3 |
) |
|
Stock-based compensation expense |
|
16.0 |
|
|
|
16.4 |
|
|
Gain on sale of fixed assets |
|
(9.3 |
) |
|
|
— |
|
|
Other, net |
|
0.8 |
|
|
|
0.6 |
|
|
Changes in operating assets and liabilities |
|
(105.2 |
) |
|
|
(85.8 |
) |
|
Net cash provided by operating activities |
|
158.4 |
|
|
|
163.3 |
|
|
|
|
|
|
||||
|
Investing Activities |
|
|
|
||||
|
Purchases of property, plant and equipment |
|
(29.2 |
) |
|
|
(44.0 |
) |
|
Proceeds from sale of property, plant and equipment |
|
10.8 |
|
|
|
0.1 |
|
|
Equity investment |
|
— |
|
|
|
(71.2 |
) |
|
Net cash used in investing activities |
|
(18.4 |
) |
|
|
(115.1 |
) |
|
|
|
|
|
||||
|
Financing Activities |
|
|
|
||||
|
Proceeds from long-term debt |
|
40.0 |
|
|
|
55.0 |
|
|
Repayments of long-term debt |
|
— |
|
|
|
(20.0 |
) |
|
Change in short-term borrowings |
|
(31.1 |
) |
|
|
10.7 |
|
|
Purchase of treasury stock |
|
(111.2 |
) |
|
|
(81.6 |
) |
|
Payment of contingent consideration |
|
— |
|
|
|
(1.8 |
) |
|
Dividends paid |
|
(69.3 |
) |
|
|
(64.6 |
) |
|
Exercise of stock options and other |
|
40.1 |
|
|
|
13.8 |
|
|
Net cash used in financing activities |
|
(131.5 |
) |
|
|
(88.5 |
) |
|
Effect of exchange rate changes on cash |
|
5.5 |
|
|
|
(3.3 |
) |
|
Increase (decrease) in cash and cash equivalents |
|
14.0 |
|
|
|
(43.6 |
) |
|
Cash and cash equivalents, beginning of period |
|
180.4 |
|
|
|
232.7 |
|
|
Cash and cash equivalents, end of period |
$ |
194.4 |
|
|
$ |
189.1 |
|
|
CONSOLIDATED RATE ANALYSIS (Unaudited) |
|||||||||||
|
|
Three Months Ended |
Six Months Ended |
|||||||||
|
|
|
|
|||||||||
|
|
2026 |
|
2025 |
|
2026 |
|
2025 |
||||
|
Gross margin |
33.5 |
% |
|
35.2 |
% |
|
34.3 |
% |
|
35.3 |
% |
|
Operating expenses |
20.2 |
% |
|
20.7 |
% |
|
19.7 |
% |
|
20.9 |
% |
|
Operating margin |
13.2 |
% |
|
14.4 |
% |
|
14.6 |
% |
|
14.5 |
% |
|
Other income, net |
(0.6 |
)% |
|
(0.6 |
)% |
|
(0.6 |
)% |
|
(0.6 |
)% |
|
Depreciation and amortization |
2.7 |
% |
|
2.9 |
% |
|
2.7 |
% |
|
2.9 |
% |
|
EBITDA |
16.6 |
% |
|
17.9 |
% |
|
17.9 |
% |
|
17.9 |
% |
|
Effective tax rate |
20.7 |
% |
|
23.2 |
% |
|
21.8 |
% |
|
23.7 |
% |
|
Earnings before income taxes - Mobile Solutions |
16.8 |
% |
|
17.4 |
% |
|
17.8 |
% |
|
17.9 |
% |
|
Earnings before income taxes - Industrial Solutions |
11.9 |
% |
|
16.1 |
% |
|
12.2 |
% |
|
16.0 |
% |
|
Earnings (loss) before income taxes - Life Sciences |
9.3 |
% |
|
(0.7 |
)% |
|
9.2 |
% |
|
(4.2 |
)% |
|
Cash conversion ratio |
19.4 |
% |
|
74.4 |
% |
|
67.8 |
% |
|
61.2 |
% |
|
|
|
|
|
|
|
|
|
||||
|
|
Three Months Ended |
Six Months Ended |
|||||||||
|
|
|
|
|||||||||
|
|
2026 |
|
2025 |
|
2026 |
|
2025 |
||||
|
Adjusted Rates |
|
|
|
|
|
|
|
||||
|
Gross margin |
33.7 |
% |
|
35.2 |
% |
|
34.5 |
% |
|
35.4 |
% |
|
Operating expenses |
19.7 |
% |
|
20.0 |
% |
|
19.8 |
% |
|
20.4 |
% |
|
Operating margin |
14.0 |
% |
|
15.2 |
% |
|
14.8 |
% |
|
15.0 |
% |
|
Other income, net |
(0.6 |
)% |
|
(0.6 |
)% |
|
(0.6 |
)% |
|
(0.6 |
)% |
|
Depreciation and amortization |
2.7 |
% |
|
2.9 |
% |
|
2.7 |
% |
|
2.9 |
% |
|
EBITDA |
17.3 |
% |
|
18.7 |
% |
|
18.0 |
% |
|
18.5 |
% |
|
Effective tax rate |
20.9 |
% |
|
23.2 |
% |
|
21.8 |
% |
|
23.7 |
% |
|
Earnings before income taxes - Mobile Solutions |
16.8 |
% |
|
17.4 |
% |
|
17.8 |
% |
|
17.9 |
% |
|
Earnings before income taxes - Industrial Solutions |
11.9 |
% |
|
16.1 |
% |
|
12.2 |
% |
|
16.0 |
% |
|
Earnings (loss) before income taxes - Life Sciences |
9.3 |
% |
|
(0.7 |
)% |
|
9.2 |
% |
|
(4.2 |
)% |
|
Cash conversion ratio |
18.4 |
% |
|
70.7 |
% |
|
62.3 |
% |
|
58.9 |
% |
|
Note: Rate analysis metrics are computed by dividing the applicable amount by net sales, and cash conversion ratio reflects free cash flow divided by net earnings. Adjusted rates exclude the impact of certain items not related to ongoing operations. Adjusted rates are non-GAAP measures; see the Reconciliation of Non-GAAP Financial Measures schedule for additional information. |
|||||||||||
|
SEGMENT DETAIL (In millions) (Unaudited) |
|||||||||||||||||||||
|
|
Three Months Ended |
|
Six Months Ended |
||||||||||||||||||
|
|
|
2026 |
|
|
|
2025 |
|
|
Change |
|
|
2026 |
|
|
|
2025 |
|
|
Change |
||
|
Net sales |
|
|
|
|
|
|
|
|
|
|
|
||||||||||
|
Mobile Solutions segment |
|
|
|
|
|
|
|
|
|
|
|
||||||||||
|
Off-Road |
$ |
86.5 |
|
|
$ |
80.2 |
|
|
7.8 |
% |
|
$ |
181.1 |
|
|
$ |
169.3 |
|
|
6.9 |
% |
|
On-Road |
|
23.0 |
|
|
|
25.3 |
|
|
(9.2 |
) |
|
|
46.4 |
|
|
|
57.4 |
|
|
(19.2 |
) |
|
Aftermarket |
|
447.1 |
|
|
|
442.0 |
|
|
1.1 |
|
|
|
927.4 |
|
|
|
893.2 |
|
|
3.8 |
|
|
Total Mobile Solutions segment |
|
556.6 |
|
|
|
547.5 |
|
|
1.6 |
|
|
|
1,154.9 |
|
|
|
1,119.9 |
|
|
3.1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||
|
Industrial Solutions segment |
|
|
|
|
|
|
|
|
|
|
|
||||||||||
|
Industrial Filtration Solutions |
|
222.6 |
|
|
|
207.5 |
|
|
7.2 |
|
|
|
438.3 |
|
|
|
419.9 |
|
|
4.4 |
|
|
Aerospace and Defense |
|
37.1 |
|
|
|
46.2 |
|
|
(19.4 |
) |
|
|
79.2 |
|
|
|
91.4 |
|
|
(13.3 |
) |
|
Total Industrial Solutions segment |
|
259.7 |
|
|
|
253.7 |
|
|
2.4 |
|
|
|
517.5 |
|
|
|
511.3 |
|
|
1.2 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||
|
Life Sciences segment |
|
|
|
|
|
|
|
|
|
|
|
||||||||||
|
Total Life Sciences segment |
|
80.0 |
|
|
|
68.8 |
|
|
16.2 |
|
|
|
159.3 |
|
|
|
138.9 |
|
|
14.6 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||
|
|
$ |
896.3 |
|
|
$ |
870.0 |
|
|
3.0 |
% |
|
$ |
1,831.7 |
|
|
$ |
1,770.1 |
|
|
3.5 |
% |
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||
|
Earnings (loss) before income taxes |
|
|
|
|
|
|
|
|
|
|
|
||||||||||
|
Mobile Solutions segment |
$ |
93.7 |
|
|
$ |
95.5 |
|
|
(1.9 |
)% |
|
$ |
205.0 |
|
|
$ |
200.2 |
|
|
2.4 |
% |
|
Industrial Solutions segment |
|
31.0 |
|
|
|
40.9 |
|
|
(24.2 |
) |
|
|
63.2 |
|
|
|
81.9 |
|
|
(22.8 |
) |
|
Life Sciences segment |
|
7.4 |
|
|
|
(0.5 |
) |
|
NM(1) |
|
|
14.7 |
|
|
|
(5.8 |
) |
|
NM(1) |
||
|
Corporate and unallocated |
|
(15.5 |
) |
|
|
(10.9 |
) |
|
(42.2 |
)% |
|
|
(18.8 |
) |
|
|
(20.8 |
) |
|
9.6 |
% |
|
|
$ |
116.6 |
|
|
$ |
125.0 |
|
|
(6.7 |
)% |
|
$ |
264.1 |
|
|
$ |
255.5 |
|
|
3.3 |
% |
|
Earnings (loss) before income taxes percentage |
|
|
|
|
|
|
|
|
|
|
|
||||||
|
Mobile Solutions segment |
16.8 |
% |
|
17.4 |
% |
|
(0.6 |
)% |
|
17.8 |
% |
|
17.9 |
% |
|
(0.1 |
)% |
|
Industrial Solutions segment |
11.9 |
% |
|
16.1 |
% |
|
(4.2 |
)% |
|
12.2 |
% |
|
16.0 |
% |
|
(3.8 |
)% |
|
Life Sciences segment |
9.3 |
% |
|
(0.7 |
)% |
|
10.0 |
% |
|
9.2 |
% |
|
(4.2 |
)% |
|
13.4 |
% |
|
Note: Earnings before income taxes percentage is calculated by dividing earnings before income taxes by net sales. Amounts may not foot due to rounding. (1) NM = not meaningful |
|||||||||||||||||
|
SEGMENT SALES PERCENT CHANGE FROM PRIOR PERIODS BY GEOGRAPHY, AS REPORTED (Unaudited) |
||||||||||||||
|
|
Three Months Ended |
|||||||||||||
|
|
TOTAL |
|
|
|
EMEA(3) |
|
APAC(4) |
|
LATAM(5) |
|||||
|
Mobile Solutions segment |
|
|
|
|
|
|
|
|
|
|||||
|
Off-Road |
7.8 |
% |
|
(7.5 |
)% |
|
21.6 |
% |
|
18.8 |
% |
|
5.9 |
% |
|
On-Road |
(9.2 |
) |
|
(18.8 |
) |
|
16.2 |
|
|
(3.8 |
) |
|
(23.0 |
) |
|
Aftermarket |
1.1 |
|
|
(2.2 |
) |
|
10.5 |
|
|
6.6 |
|
|
(6.7 |
) |
|
Total Mobile Solutions segment |
1.6 |
|
|
(3.9 |
) |
|
12.9 |
|
|
8.1 |
|
|
(6.3 |
) |
|
|
|
|
|
|
|
|
|
|
|
|||||
|
Industrial Solutions segment |
|
|
|
|
|
|
|
|
|
|||||
|
Industrial Filtration Solutions |
7.2 |
|
|
(0.3 |
) |
|
19.5 |
|
|
6.2 |
|
|
5.8 |
|
|
Aerospace and Defense |
(19.4 |
) |
|
(32.8 |
) |
|
37.2 |
|
|
(22.1 |
) |
|
N/A |
|
|
Total Industrial Solutions segment |
2.4 |
|
|
(8.8 |
) |
|
21.5 |
|
|
5.4 |
|
|
5.8 |
|
|
|
|
|
|
|
|
|
|
|
|
|||||
|
Life Sciences segment |
|
|
|
|
|
|
|
|
|
|||||
|
Total Life Sciences segment |
16.2 |
|
|
27.6 |
|
|
14.7 |
|
|
13.7 |
|
|
(0.6 |
) |
|
|
|
|
|
|
|
|
|
|
|
|||||
|
|
3.0 |
% |
|
(4.7 |
)% |
|
16.0 |
% |
|
8.7 |
% |
|
(5.2 |
)% |
|
|
|
|
|
|
|
|
|
|
|
|||||
|
|
Six Months Ended |
|||||||||||||
|
|
TOTAL |
|
|
|
EMEA |
|
APAC |
|
LATAM |
|||||
|
Mobile Solutions segment |
|
|
|
|
|
|
|
|
|
|||||
|
Off-Road |
6.9 |
% |
|
(2.8 |
)% |
|
9.4 |
% |
|
22.2 |
% |
|
14.1 |
% |
|
On-Road |
(19.2 |
) |
|
(30.5 |
) |
|
9.8 |
|
|
(6.6 |
) |
|
(50.0 |
) |
|
Aftermarket |
3.8 |
|
|
2.0 |
|
|
7.5 |
|
|
6.5 |
|
|
1.0 |
|
|
Total Mobile Solutions segment |
3.1 |
|
|
(0.8 |
) |
|
8.0 |
|
|
8.3 |
|
|
0.9 |
|
|
|
|
|
|
|
|
|
|
|
|
|||||
|
Industrial Solutions segment |
|
|
|
|
|
|
|
|
|
|||||
|
Industrial Filtration Solutions |
4.4 |
|
|
(2.2 |
) |
|
18.7 |
|
|
(0.7 |
) |
|
(5.4 |
) |
|
Aerospace and Defense |
(13.3 |
) |
|
(24.8 |
) |
|
36.1 |
|
|
(10.0 |
) |
|
N/A |
|
|
Total Industrial Solutions segment |
1.2 |
|
|
(7.9 |
) |
|
20.7 |
|
|
(0.9 |
) |
|
(5.4 |
) |
|
|
|
|
|
|
|
|
|
|
|
|||||
|
Life Sciences segment |
|
|
|
|
|
|
|
|
|
|||||
|
Total Life Sciences segment |
14.6 |
|
|
25.6 |
|
|
11.9 |
|
|
13.5 |
|
|
(1.4 |
) |
|
|
|
|
|
|
|
|
|
|
|
|||||
|
|
3.5 |
% |
|
(2.6 |
)% |
|
12.4 |
% |
|
7.6 |
% |
|
0.3 |
% |
|
|
|
|
|
|
|
|
|
|
|
|||||
|
Note: Amounts may not foot due to rounding.
(1)
(2)
(3)
(4)
(5)
|
||||||||||||||
|
SEGMENT SALES PERCENT CHANGE FROM PRIOR PERIODS BY GEOGRAPHY, CONSTANT CURRENCY (Unaudited) |
||||||||||||||
|
|
Three Months Ended |
|||||||||||||
|
|
TOTAL |
|
|
|
EMEA |
|
APAC |
|
LATAM |
|||||
|
Mobile Solutions segment |
|
|
|
|
|
|
|
|
|
|||||
|
Off-Road |
4.1 |
% |
|
(7.5 |
)% |
|
9.4 |
% |
|
19.7 |
% |
|
4.8 |
% |
|
On-Road |
(11.3 |
) |
|
(18.8 |
) |
|
3.7 |
|
|
(3.7 |
) |
|
(26.3 |
) |
|
Aftermarket |
(1.9 |
) |
|
(2.3 |
) |
|
(0.6 |
) |
|
5.9 |
|
|
(8.8 |
) |
|
Total Mobile Solutions segment |
(1.4 |
) |
|
(4.0 |
) |
|
1.5 |
|
|
7.7 |
|
|
(8.4 |
) |
|
|
|
|
|
|
|
|
|
|
|
|||||
|
Industrial Solutions segment |
|
|
|
|
|
|
|
|
|
|||||
|
Industrial Filtration Solutions |
4.6 |
|
|
(0.9 |
) |
|
13.7 |
|
|
5.4 |
|
|
(2.1 |
) |
|
Aerospace and Defense |
(19.5 |
) |
|
(30.1 |
) |
|
23.0 |
|
|
(2.0 |
) |
|
N/A |
|
|
Total Industrial Solutions segment |
0.2 |
|
|
(8.5 |
) |
|
14.7 |
|
|
5.2 |
|
|
(2.1 |
) |
|
|
|
|
|
|
|
|
|
|
|
|||||
|
Life Sciences segment |
|
|
|
|
|
|
|
|
|
|||||
|
Total Life Sciences segment |
9.8 |
|
|
27.6 |
|
|
2.8 |
|
|
9.3 |
|
|
(3.4 |
) |
|
|
|
|
|
|
|
|
|
|
|
|||||
|
|
(0.1 |
)% |
|
(4.6 |
)% |
|
6.1 |
% |
|
7.5 |
% |
|
(7.8 |
)% |
|
|
|
|
|
|
|
|
|
|
|
|||||
|
|
Six Months Ended |
|||||||||||||
|
|
TOTAL |
|
|
|
EMEA |
|
APAC |
|
LATAM |
|||||
|
Mobile Solutions segment |
|
|
|
|
|
|
|
|
|
|||||
|
Off-Road |
4.4 |
% |
|
(2.8 |
)% |
|
0.7 |
% |
|
24.0 |
% |
|
12.8 |
% |
|
On-Road |
(20.5 |
) |
|
(30.5 |
) |
|
0.6 |
|
|
(5.8 |
) |
|
(51.5 |
) |
|
Aftermarket |
1.8 |
|
|
2.0 |
|
|
(0.7 |
) |
|
7.3 |
|
|
(0.5 |
) |
|
Total Mobile Solutions segment |
1.0 |
|
|
(0.8 |
) |
|
(0.4 |
) |
|
9.3 |
|
|
(0.7 |
) |
|
|
|
|
|
|
|
|
|
|
|
|||||
|
Industrial Solutions segment |
|
|
|
|
|
|
|
|
|
|||||
|
Industrial Filtration Solutions |
2.5 |
|
|
(2.5 |
) |
|
13.7 |
|
|
(0.4 |
) |
|
(9.6 |
) |
|
Aerospace and Defense |
(14.0 |
) |
|
(23.4 |
) |
|
25.2 |
|
|
2.4 |
|
|
N/A |
|
|
Total Industrial Solutions segment |
(0.4 |
) |
|
(7.8 |
) |
|
15.0 |
|
|
(0.3 |
) |
|
(9.6 |
) |
|
|
|
|
|
|
|
|
|
|
|
|||||
|
Life Sciences segment |
|
|
|
|
|
|
|
|
|
|||||
|
Total Life Sciences segment |
9.8 |
|
|
25.6 |
|
|
2.9 |
|
|
10.4 |
|
|
(3.3 |
) |
|
|
|
|
|
|
|
|
|
|
|
|||||
|
|
1.3 |
% |
|
(2.6 |
)% |
|
4.8 |
% |
|
7.7 |
% |
|
(1.5 |
)% |
|
|
|
|
|
|
|
|
|
|
|
|||||
|
Note: The constant currency presentation, which is a non-GAAP measure, excludes the impact of fluctuations in foreign currency exchange rates. The Company believes providing constant currency information provides valuable supplemental information regarding its results of operations. The Company calculates constant currency percentages by converting its current period local currency financial results using the prior period exchange rates and compares these adjusted amounts to its prior period reported results. Amounts may not foot due to rounding. |
||||||||||||||
|
RECONCILIATION OF NON-GAAP FINANCIAL MEASURES (In millions) (Unaudited) |
|||||||||||||||
|
|
Three Months Ended |
|
Six Months Ended |
||||||||||||
|
|
|
|
|
||||||||||||
|
|
|
2026 |
|
|
|
2025 |
|
|
|
2026 |
|
|
|
2025 |
|
|
Net cash provided by operating activities |
$ |
33.0 |
|
|
$ |
90.4 |
|
|
$ |
158.4 |
|
|
$ |
163.3 |
|
|
Net capital expenditures |
|
(15.0 |
) |
|
|
(18.9 |
) |
|
|
(28.7 |
) |
|
|
(43.9 |
) |
|
Free cash flow |
$ |
18.0 |
|
|
$ |
71.5 |
|
|
$ |
129.7 |
|
|
$ |
119.4 |
|
|
|
|
|
|
|
|
|
|
||||||||
|
Net earnings |
$ |
92.5 |
|
|
$ |
95.9 |
|
|
$ |
206.4 |
|
|
$ |
194.9 |
|
|
Income taxes |
|
24.1 |
|
|
|
29.1 |
|
|
|
57.7 |
|
|
|
60.6 |
|
|
Interest expense |
|
7.7 |
|
|
|
5.9 |
|
|
|
14.8 |
|
|
|
11.4 |
|
|
Depreciation and amortization |
|
24.6 |
|
|
|
25.0 |
|
|
|
48.9 |
|
|
|
50.5 |
|
|
EBITDA |
$ |
148.9 |
|
|
$ |
155.9 |
|
|
$ |
327.8 |
|
|
$ |
317.4 |
|
|
|
|
|
|
|
|
|
|
||||||||
|
Adjusted net earnings |
$ |
97.5 |
|
|
$ |
101.0 |
|
|
$ |
208.2 |
|
|
$ |
202.5 |
|
|
Adjusted income taxes |
|
25.7 |
|
|
|
30.6 |
|
|
|
58.2 |
|
|
|
62.9 |
|
|
Interest expense |
|
7.7 |
|
|
|
5.9 |
|
|
|
14.8 |
|
|
|
11.4 |
|
|
Depreciation and amortization |
|
24.6 |
|
|
|
25.0 |
|
|
|
48.9 |
|
|
|
50.5 |
|
|
Adjusted EBITDA |
$ |
155.5 |
|
|
$ |
162.5 |
|
|
$ |
330.1 |
|
|
$ |
327.3 |
|
|
|
|
|
|
|
|
|
|
||||||||
|
Gross profit |
$ |
299.8 |
|
|
$ |
305.9 |
|
|
$ |
628.6 |
|
|
$ |
625.5 |
|
|
Restructuring and other charges |
|
2.2 |
|
|
|
0.6 |
|
|
|
4.2 |
|
|
|
1.7 |
|
|
Adjusted gross profit |
$ |
302.0 |
|
|
$ |
306.5 |
|
|
$ |
632.8 |
|
|
$ |
627.2 |
|
|
|
|
|
|
|
|
|
|
||||||||
|
Operating expense |
$ |
181.1 |
|
|
$ |
180.4 |
|
|
$ |
360.6 |
|
|
$ |
369.2 |
|
|
Restructuring and other charges |
|
(0.7 |
) |
|
|
(1.6 |
) |
|
|
(3.7 |
) |
|
|
(3.8 |
) |
|
Business development charges |
|
(3.8 |
) |
|
|
(4.4 |
) |
|
|
(3.8 |
) |
|
|
(4.4 |
) |
|
Gain on the sale of fixed assets |
|
— |
|
|
|
— |
|
|
|
9.3 |
|
|
|
— |
|
|
Adjusted operating expense |
$ |
176.6 |
|
|
$ |
174.4 |
|
|
$ |
362.4 |
|
|
$ |
361.0 |
|
|
|
|
|
|
|
|
|
|
||||||||
|
Operating income |
$ |
118.7 |
|
|
$ |
125.5 |
|
|
$ |
268.0 |
|
|
$ |
256.3 |
|
|
Restructuring and other charges |
|
2.9 |
|
|
|
2.2 |
|
|
|
7.9 |
|
|
|
5.5 |
|
|
Business development charges |
|
3.8 |
|
|
|
4.4 |
|
|
|
3.8 |
|
|
|
4.4 |
|
|
Gain on the sale of fixed assets |
|
— |
|
|
|
— |
|
|
|
(9.3 |
) |
|
|
— |
|
|
Adjusted operating income |
$ |
125.4 |
|
|
$ |
132.1 |
|
|
$ |
270.4 |
|
|
$ |
266.2 |
|
|
|
|
|
|
|
|
|
|
||||||||
|
Net earnings |
$ |
92.5 |
|
|
$ |
95.9 |
|
|
$ |
206.4 |
|
|
$ |
194.9 |
|
|
Restructuring and other charges, net tax |
|
2.1 |
|
|
|
1.7 |
|
|
|
5.9 |
|
|
|
4.2 |
|
|
Business development charges, net tax |
|
2.9 |
|
|
|
3.4 |
|
|
|
2.9 |
|
|
|
3.4 |
|
|
Gain on the sale of fixed assets, net tax |
|
— |
|
|
|
— |
|
|
|
(7.0 |
) |
|
|
— |
|
|
Adjusted net earnings |
$ |
97.5 |
|
|
$ |
101.0 |
|
|
|
208.2 |
|
|
$ |
202.5 |
|
|
|
|
|
|
|
|
|
|
||||||||
|
Diluted EPS |
$ |
0.78 |
|
|
$ |
0.79 |
|
|
$ |
1.75 |
|
|
$ |
1.60 |
|
|
Restructuring and other charges per share |
|
0.02 |
|
|
|
0.01 |
|
|
|
0.05 |
|
|
|
0.03 |
|
|
Business development charges per share |
|
0.03 |
|
|
|
0.03 |
|
|
|
0.03 |
|
|
|
0.03 |
|
|
Gain on the sale of fixed assets per share |
|
— |
|
|
|
— |
|
|
|
(0.06 |
) |
|
|
— |
|
|
Adjusted diluted EPS |
$ |
0.83 |
|
|
$ |
0.83 |
|
|
$ |
1.77 |
|
|
$ |
1.66 |
|
2026 Adjusted EPS Guidance
A reconciliation of the Company’s fiscal 2026 adjusted EPS guidance to fiscal 2026 GAAP EPS guidance is not included in this release due to the number of variables in the projected GAAP EPS range and the Company’s current inability to reasonably quantify certain amounts, such as restructuring or other charges, that would be included in the GAAP measure or the individual adjustments for such reconciliation.
Note: Although free cash flow, EBITDA, adjusted EBITDA, adjusted gross profit, adjusted operating expense, adjusted operating income, adjusted net earnings and adjusted diluted EPS are not measures of financial performance under GAAP, the Company believes they are useful in understanding its financial results. Free cash flow is a commonly used measure of a company’s ability to generate cash in excess of its operating needs. EBITDA is a commonly used measure of operating earnings less non-cash expenses. The adjusted basis presentation excludes the impact of certain matters not related to the Company’s ongoing operations. Management believes that the adjusted basis presentation reflects management’s performance in operating the Company and provides a meaningful representation of the performance of the Company’s core business and is useful to understanding its financial results. A shortcoming of these financial measures is that they do not reflect the Company’s actual results under GAAP. Management does not intend these items to be considered in isolation or as a substitute for the related GAAP measures. Amounts may not foot due to rounding.
View source version on businesswire.com: https://www.businesswire.com/news/home/20260226184143/en/
For more information, contact:
Sarika.Dhadwal@Donaldson.com
Source: